Baidu
map
CANCER NANOTECHNOL 润色咨询

Cancer Nanotechnology

出版年份:暂无数据 年文章数:151 投稿命中率: 开通期刊会员,数据随心看

出版周期:C 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=82d716468, cover=https://img.medsci.cn/images/journal/cover/2021/jeF_202109271314377740.jpg, fullname=Cancer Nanotechnology, abbr=CANCER NANOTECHNOL, pyear=暂无数据, frequence=C, articleNumbers=151, citedSelf2015=null, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=暂无数据, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1868-6958, greenSci=https://www.greensci.net/search?kw=1868-6958, scijournal=https://www.scijournal.org/impact-factor-of-CANCER-NANOTECHNOL.shtml, medsciHotlightString=null, medsciHotlightRealtime=1.24, medsciHotlight=0.911, medsciHotlight5year=0.490667, citescore=5.2, hIndex=25, impactFactor=5.7, orgnization=Springer Science + Business Media, orgnizationUrl=https://www.biomedcentral.com/, country=United States, countryCn=美国, isOa=1, isOaString=是, sciScie=SCIE, bigclassCas=null, smallclassCas=工程技术 2 区, website=https://cancer-nano.biomedcentral.com/, websiteHits=273, guideForAuthor=https://cancer-nano.biomedcentral.com/submission-guidelines, guideForAuthorHits=150, submitWebsite=https://www.editorialmanager.com/cano, submitWebsiteHits=257, content=<p><span style="color: #333333;">Cancer is a group of diseases driven by inherently nanostructural problems (e.g. DNA issues). As such, there are obvious benefits to treatments employing nanoscale structures and processes. Additionally, as nanotechnologies are developing at a rapid rate, it is likely that many new themes will develop within the area in the next few years. With this in mind, </span><em style="color: #333333;">Cancer Nanotechnology</em><span style="color: #333333;"> aims to provide a forum so that the most promising emerging themes should be pre-eminent in the minds of researchers working in one—or, indeed, both—of the disciplines of cancer research or nanotechnology.</span></p> <p><span style="color: #333333;"><strong>Speed</strong><br />77 days to first decision for reviewed manuscripts only<br />67 days to first decision for all manuscripts<br />120 days from submission to acceptance<br />17 days from acceptance to publication</span></p>, totalCites=866, brief=CANCER NANOTECHNOL杂志暂不明确行业,暂不明确子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=CANCER NANOTECHNOL杂志级别还可以,但是相对来说,比较冷门,关注人数偏少,有些可能是国内不太熟悉,但该杂志在国际仍然有相当知晓度的。因为缺少中国人投稿,稿源可能未必丰富,发表有可能有很大的机会哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='//m.capotfarm.com/sci/submit.do?id=82d716468'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=null, citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2020, citescore=8.0), GetImpactFactorCiteScoreListResponse(year=2023, citescore=5.2)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=0.435), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=1.037), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=1.24), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=1.43), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=1.24)], citeScoreGradeList=[], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1868-6958[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Cancer Nanotechnology[ta], article_number=44, article_number_cn=20, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
CANCER NANOTECHNOL/Cancer Nanotechnology
ISSN
1868-6958
影响指数话题
预警等级
MedSci期刊指数
1.24 (MedSci实时期刊指数) | 0.490667 (5年期刊指数)
CiteScore值
5.2
h-index
25
h5-median
暂无数据
出版社/管理机构
杂志由 Springer Science + Business Media 出版或管理
出版国家/地区
United States 美国
出版周期
C
出版年份
暂无数据
是否OA
被收录情况
SCIE
JCR分区
暂无数据
中科院分区
大类:
小类:工程技术 2 区
Baidu
map
Baidu
map
Baidu
map